Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2005

Isolation and characterization of unserotypable lysogens of Vibrio choleraephage PS166.

Siddhartha Basu, Ranajit K. Ghosh

Med Sci Monit 2005; 11(9): BR335-342 :: ID: 428445


Background: Temperate phages of Vibrio cholerae are the major force inthe emergence of newer pathogenic clones. PS166, a temperate vibriophage, has the ability to convertpathogenic biotypes of the V. Cholerae O1 serogroup. During the conversion process, PS166 also tendsto produce a group of lysogens neither reported nor characterized so far. Characterization of those lysogensmay provide insight into the emergence of newer pathogenic clones of V. Cholerae. Material/Methods: TheV. cholerae eltor strain MAK757 was used to generate PS166 lysogens which were serotyped by using antiseraspecific to V. Cholerae O1 and O139 strains. Multiplex PCR was used to compare the status of variouspathogenic markers of those lysogens. The outer membrane proteins (OMP) of the lysogens were determinedby SDS-PAGE. Results: Temperate phage PS166 infection of V. cholerae eltor MAK757 gave rise to a newkind of lysogens termed unserotypable due to their lack of reactivity to both O1 and O139 antisera. Moreover,these lysogens displayed a new phage sensitivity profile different from both classical and parental eltorbiotypes. The genetic profiles of the CTX element and VPI region of these lysogens were found to be unaltered,together with the biotype-specific markers mshA and hlyA. Though the genetic loci of major outer membraneproteins did not change after lysogenization, the outer membrane protein profile of these lysogens showedthe absence of a 40-kDa band corresponding to the toxR-controlled porin, ompT. Conclusions: We provideevidence for the vibriophage PS166-mediated lysogenic conversion of pathogenic cholera strains.

Keywords: DNA, Bacterial - genetics, Base Sequence, Bacteriophages - pathogenicity, Genes, Bacterial, Genetic Markers, Lysogeny - genetics, Serotyping, Vibrio cholerae - virology, Vibrio cholerae O1 - virology, Vibrio cholerae non-O1 - virology

Add Comment 0 Comments

521 3


01 May 2023 : Editorial  

Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.940911

Med Sci Monit 2023; 29:e940911

In Press

28 May 2023 : Database Analysis  

Scientometric and Visualized Analysis of Intravoxel Incoherent Motion Magnetic Resonance Imaging: 1988-2021

Med Sci Monit In Press; DOI: 10.12659/MSM.938715  

25 May 2023 : Database Analysis  

The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940904  

25 May 2023 : Review article  

A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drug...

Med Sci Monit In Press; DOI: 10.12659/MSM.940635  

25 May 2023 : Clinical Research  

Periapical Lesions and Missed Canals in Endodontically Treated Teeth: A Cone-Beam Computed Tomographic Stud...

Med Sci Monit In Press; DOI: 10.12659/MSM.940533  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750